Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
14.42
+1.07 (8.01%)
At close: Apr 16, 2026, 4:00 PM EDT
14.84
+0.42 (2.91%)
After-hours: Apr 16, 2026, 6:21 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $328.61 million as of April 16, 2026. Its market cap has increased by 284.34% in one year.
Market Cap
328.61M
Enterprise Value
232.18M
1-Year Change
284.34%
Ranking
Category
Stock Price
$14.42
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $328.61M, an increase of 852.49%. That is a compound annual growth rate of 24.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 304.20M | -7.62% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 311.49M |
| Abeona Therapeutics | 308.06M |
| Polaryx Therapeutics | 305.84M |
| Inhibikase Therapeutics | 305.06M |
| Cellectis | 304.73M |
| NovaBridge Biosciences | 300.69M |
| LENZ Therapeutics | 300.38M |
| Anavex Life Sciences | 300.26M |